Practice-changing literature and congress updates for oncologists

Oncology Compass features a library of selected key publications and congress updates which can be searched by clinical characteristics.

Regular updates from leading medical journals and congresses

All materials are carefully selected and reviewed by the scientific board

Filter by clinical characteristics: easily find relevant publications

Banner

Triple-negative breast cancer — a new indication on the platform

Explore our publications >

Oncology Compass bridges the gap between progression of research in cancer treatment and finding relevant data, providing information about the most relevant cancer treatment practices.

0

practice-changing publications are on the platform

10 cancer indications are available on the platform:

Non-Small Cell Lung Cancer (NSCLC)

Gastric Cancer

Multiple Myeloma

Esophageal Cancer

Renal Cell Carcinoma

Prostate Cancer

Mesothelioma

Small Cell Lung Cancer (SCLC)

Melanoma

TNBC

Doctor

Oncology news

Weekly updates


Figure

News for the Oncologist

April 05, 2025


Upcoming conferences

Monthly updates


Figure

A very useful tool, which saves a lot of time in daily practice by facilitating the search for the most important data.”

Dr. med. Michael Thomas Mark

Dr. med. Michael Thomas Mark

Kantonsspital Graubünden

Figure

Oncology Compass Digest

We're excited to announce the upcoming quarterly publication of the “Oncology Compass Digest”. This edition will feature congress news, intriguing interviews, and insights particularly interesting for oncologists and pharma marketers.
Figure
Scientific board you can trust

The scientific board selects updates from top medical journals and conferences for you. The filtering system helps you find relevant articles with ease.

Kantonsspital GraubundenHopitaux Universitaires GeneveEOCUniversitatsspital BaselKantonsspital WinterthurCHUVHirslandenInVOKantonsspital GraubundenHopitaux Universitaires GeneveEOCUniversitatsspital BaselKantonsspital WinterthurCHUVHirslandenInVO

Explore practice-changing literature for oncologists

Doctors only

Education purpose only

Not promoting any product or professional services

Help us to provide more relevant information for you

We value your feedback and suggestions. Take a quick 5-minute survey to let us know your thoughts.

Leave your feedback

Owned by Capptoo AG

Initiated by MSD Merck Sharp & Dohme AG

Generously sponsored by AMGEN, Roche, AstraZeneca, Takeda and Gilead


Copyright © Capptoo AG - 2025, Zürich, Switzerland. All rights reserved.